X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.020
+0.030 (0.75%)
At close: Jun 26, 2026, 4:00 PM EDT
4.040
+0.020 (0.50%)
After-hours: Jun 26, 2026, 6:46 PM EDT
X4 Pharmaceuticals Employees
X4 Pharmaceuticals had 45 employees as of December 31, 2025. The number of employees decreased by 98 or -68.53% compared to the previous year.
Employees
45
Change (1Y)
-98
Growth (1Y)
-68.53%
Revenue / Employee
$200,311
Profits / Employee
-$2,216,044
Market Cap
379.17M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Adlai Nortye | 109 |
| OmniAb | 89 |
| Upstream Bio | 75 |
| Larimar Therapeutics | 71 |
| Lexeo Therapeutics | 59 |
| Atea Pharmaceuticals | 55 |
| Cybin | 50 |
XFOR News
- 23 days ago - X4 Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 25 days ago - X4 Pharmaceuticals initiated with an Outperform at Leerink - TheFly
- 26 days ago - X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - X4 Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - X4 Pharmaceuticals reports Q1 EPS (16c), consensus (20c) - TheFly
- 7 weeks ago - X4 Pharmaceuticals files $300M mixed securities shelf - TheFly
- 7 weeks ago - X4 Pharmaceuticals Registration statement: Registration filing - Filings
- 7 weeks ago - X4 Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire